doi: 10.1111/j.1753-0407.2010.00093.x
Journal of Diabetes 2 (2010) 127
EDITORIAL
Good news! We are very pleased to share with our readers that the Journal of Diabetes has been accepted by MEDLINE, starting with Volume 1, Issue 1, based on our excellent performance during the first year of publication. MEDLINE is the US National Library of Medicine’s bibliographic database of articles in the life sciences, with journals selected for MEDLINE based on the recommendation of a National Institutes of Healthchartered advisory committee of external experts (http://www.nlm.nih.gov/pubs/factsheets/medline.html). The rapid acceptance of the journal as a participant in the community of medical scientists endeavoring to improve the understanding of diabetes reflects the importance of its mission to bring together studies of diabetes research, therapeutics, and education based on the efforts of an international editorial team with a unique mix of Asian and Western participation. In our endeavor to further this process we look forward to further contributions from you, our readers. With burgeoning numbers of people with diabetes throughout the world, the development of effective and affordable treatments of the varying aspects of the condition is being addressed in many different ways in different countries. We welcome studies of how diabetes treatment is being differently implemented for diabetes in different regions of the world. Recognizing the similarity of diabetic complications in all people, in all countries, we expect that the economics of diabetes will vary, and look forward to publications summarizing the lessons and experiences of various ‘‘developed’’ and ‘‘developing’’ countries. We welcome comparative effectiveness research studies that generate and synthesize evidence comparing the benefits and risks of varying methods to prevent, diagnose, treat and monitor diabetes, and to improve the delivery of care. Clinical trials are crucial in the management of diabetes and, in addition to trial outcomes, we will make a point of accepting submissions describing important clinical trials that allow insight into appropriate approaches. Hypothesis papers, papers describing controversies, discussions of inpatient and outpatient management, both of glycemic and non-glycemic aspects of diabetes, and discussions of approaches to the translation of basic research into clinical care all are welcome. We look forward to proposals to publish symposia on specific topics, not only dealing with clinical treatments, but also as pertaining to basic aspects of the science of diabetes, such as the development of new animal models to understand clinical disease. Manuscripts defining the mechanisms and clinical utility of vitamins and supplements in the
treatment of aspects of diabetes and the scientific basis of ‘‘traditional’’ medications will also be important. We encourage the submission of manuscripts by all healthcare professionals: physicians, pharmacists, nurses and nutritionists, and would be interested as well in submissions by people who themselves have diabetes. Finally, as part of our effort to encourage new researchers and to celebrate the successful launch of the Journal of Diabetes, we would like to remind our readers of our Young Clinician Investigator Award of US$2000 for a student, resident, fellow or junior faculty member aged 35 or younger, as well as a US$1000 stipend to be used for travel to attend the Annual Meeting of the Chinese Society of Endocrinology to give an oral presentation. Editors-in-Chief Zachary T. Bloomgarden Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA Email:
[email protected] Guang Ning Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital affiliated to Jiao Tong University School of Medicine, Shanghai, China Email:
[email protected] Associate Editors Andrew J. Drexler Gonda (Goldschmied) Diabetes Center, Los Angeles, CA, USA Email:
[email protected] You-Fei Guan Department of Physiology and Pathophysiology, Beijing University, Beijing, China Email:
[email protected] Yehuda Handelsman Metabolic Institute of America, Tanzana, CA, USA Email:
[email protected] Xiao-Ying Li Shanghai Institute of Endocrinology and Metabolism, Shanghai, China Email:
[email protected] Jian-Min Liu Department of Endocrinology and Metabolism, Ruijin Hospital affiliated to Jiao Tong University School of Medicine, Shanghai, China Email:
[email protected]
ª 2010 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd
127
